img

Yeast Expression Vector Market Status and Trend Analysis 2017-2034 (COVID-19 Version)


Published on: 2024-01-04 | No of Pages : 98 | Industry : Life & Medical

Publisher : 9 | Format : PDF

Yeast Expression Vector Market Status and Trend Analysis 2017-2034 (COVID-19 Version)

Summary

Further key aspects of the report indicate that
Chapter 1Research ScopeProduct Definition, Type, End-Use & Methodology
Chapter 2Global Industry Summary
Chapter 3Market Dynamics
Chapter 4Global Market Segmentation by region, type and End-Use
Chapter 5North America Market Segmentation by region, type and End-Use
Chapter 6Europe Market Segmentation by region, type and End-Use
Chapter 7Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8South America Market Segmentation by region, type and End-Use
Chapter 9Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10Market Competition by Companies
Chapter 11Market forecast and environment forecast.
Chapter 12Industry Summary.

The global Yeast Expression Vector market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.


Based on the type of product

the global Yeast Expression Vector market segmented into
K. Lactis Expression Vectors
Pichia Pastoris Expression Vectors
Saccharomyces Cerevisiae Expression Vectors
Others

Based on the end-use

the global Yeast Expression Vector market classified into
Therapeutic
Research
Industrial

Based on geography

the global Yeast Expression Vector market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are


Thermo Fisher Scientific, Inc. (U.S.)
Promega Corporation (U.S.)
Sigma-Aldrich Corporation (U.S.)
Agilent Technologies (U.S.)
Bio-Rad Laboratories (U.S.)
New England Biolabs (U.S.)
Merck Millipore (U.S.)
QIAGEN (Netherlands)
Clontech Laboratories, Inc. (U.S.)
DNA2.0 (U.S.)
GenScript USA Inc. (U.S.)

Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL YEAST EXPRESSION VECTOR INDUSTRY
2.1 Summary about Yeast Expression Vector Industry
2.2 Yeast Expression Vector Market Trends
2.2.1 Yeast Expression Vector Production & Consumption Trends
2.2.2 Yeast Expression Vector Demand Structure Trends
2.3 Yeast Expression Vector Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 K. Lactis Expression Vectors
4.2.2 Pichia Pastoris Expression Vectors
4.2.3 Saccharomyces Cerevisiae Expression Vectors
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Therapeutic
4.3.2 Research
4.3.3 Industrial
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 K. Lactis Expression Vectors
5.2.2 Pichia Pastoris Expression Vectors
5.2.3 Saccharomyces Cerevisiae Expression Vectors
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Therapeutic
5.3.2 Research
5.3.3 Industrial
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 K. Lactis Expression Vectors
6.2.2 Pichia Pastoris Expression Vectors
6.2.3 Saccharomyces Cerevisiae Expression Vectors
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Therapeutic
6.3.2 Research
6.3.3 Industrial
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 K. Lactis Expression Vectors
7.2.2 Pichia Pastoris Expression Vectors
7.2.3 Saccharomyces Cerevisiae Expression Vectors
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Therapeutic
7.3.2 Research
7.3.3 Industrial
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 K. Lactis Expression Vectors
8.2.2 Pichia Pastoris Expression Vectors
8.2.3 Saccharomyces Cerevisiae Expression Vectors
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Therapeutic
8.3.2 Research
8.3.3 Industrial
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 K. Lactis Expression Vectors
9.2.2 Pichia Pastoris Expression Vectors
9.2.3 Saccharomyces Cerevisiae Expression Vectors
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Therapeutic
9.3.2 Research
9.3.3 Industrial
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Thermo Fisher Scientific, Inc. (U.S.)
10.1.2 Promega Corporation (U.S.)
10.1.3 Sigma-Aldrich Corporation (U.S.)
10.1.4 Agilent Technologies (U.S.)
10.1.5 Bio-Rad Laboratories (U.S.)
10.1.6 New England Biolabs (U.S.)
10.1.7 Merck Millipore (U.S.)
10.1.8 QIAGEN (Netherlands)
10.1.9 Clontech Laboratories, Inc. (U.S.)
10.1.10 DNA2.0 (U.S.)
10.1.11 GenScript USA Inc. (U.S.)
10.2 Yeast Expression Vector Sales Date of Major Players (2017-2020e)
10.2.1 Thermo Fisher Scientific, Inc. (U.S.)
10.2.2 Promega Corporation (U.S.)
10.2.3 Sigma-Aldrich Corporation (U.S.)
10.2.4 Agilent Technologies (U.S.)
10.2.5 Bio-Rad Laboratories (U.S.)
10.2.6 New England Biolabs (U.S.)
10.2.7 Merck Millipore (U.S.)
10.2.8 QIAGEN (Netherlands)
10.2.9 Clontech Laboratories, Inc. (U.S.)
10.2.10 DNA2.0 (U.S.)
10.2.11 GenScript USA Inc. (U.S.)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Yeast Expression Vector Product Type Overview
Table Yeast Expression Vector Product Type Market Share List
Table Yeast Expression Vector Product Type of Major Players
Table Brief Introduction of Thermo Fisher Scientific, Inc. (U.S.)
Table Brief Introduction of Promega Corporation (U.S.)
Table Brief Introduction of Sigma-Aldrich Corporation (U.S.)
Table Brief Introduction of Agilent Technologies (U.S.)
Table Brief Introduction of Bio-Rad Laboratories (U.S.)
Table Brief Introduction of New England Biolabs (U.S.)
Table Brief Introduction of Merck Millipore (U.S.)
Table Brief Introduction of QIAGEN (Netherlands)
Table Brief Introduction of Clontech Laboratories, Inc. (U.S.)
Table Brief Introduction of DNA2.0 (U.S.)
Table Brief Introduction of GenScript USA Inc. (U.S.)
Table Products & Services of Thermo Fisher Scientific, Inc. (U.S.)
Table Products & Services of Promega Corporation (U.S.)
Table Products & Services of Sigma-Aldrich Corporation (U.S.)
Table Products & Services of Agilent Technologies (U.S.)
Table Products & Services of Bio-Rad Laboratories (U.S.)
Table Products & Services of New England Biolabs (U.S.)
Table Products & Services of Merck Millipore (U.S.)
Table Products & Services of QIAGEN (Netherlands)
Table Products & Services of Clontech Laboratories, Inc. (U.S.)
Table Products & Services of DNA2.0 (U.S.)
Table Products & Services of GenScript USA Inc. (U.S.)
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Yeast Expression Vector Market Forecast (Million USD) by Region 2021f-2026f
Table Global Yeast Expression Vector Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Yeast Expression Vector Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Yeast Expression Vector Market Forecast (Million USD) Share by Demand 2021f-2026f